Advertisement

Ads Placeholder
Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
Healthcare
Biotechnology
$9.10
$0.21(2.36%)
U.S. Market opens in 6h 41m

WuXi Biologics (Cayman) Inc. (WXXWY) Stock Competitors & Peer Comparison

See (WXXWY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXXWY$9.10+2.36%18.7B26.59$0.34N/A
NONOF$37.12+5.97%159.3B10.07$3.56+3.97%
CSLLY$24.98-0.60%96.9B16.25$1.54+2.92%
UCBJY$159.36+2.13%60.7B34.27$4.65+0.50%
UCBJF$318.65-2.37%60.7B34.34$9.28+0.50%
CMXHF$98.24+11.26%47.7B15.92$6.17+2.96%
ARGNF$712.03+0.00%44.1B36.36$19.58N/A
IVBXF$11.15-2.19%19.2B159.21$0.07N/A
WXIBF$4.60+0.00%19B27.06$0.17N/A
GNMSF$298.38+6.16%18.4B19.43$15.36N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXXWY vs NONOF Comparison April 2026

WXXWY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXXWY stands at 18.7B. In comparison, NONOF has a market cap of 159.3B. Regarding current trading prices, WXXWY is priced at $9.10, while NONOF trades at $37.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXXWY currently has a P/E ratio of 26.59, whereas NONOF's P/E ratio is 10.07. In terms of profitability, WXXWY's ROE is +0.11%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, WXXWY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXXWY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions